These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36177579)

  • 1. [Clinical characteristics of severe late-onset ovarian hyperstimulation syndrome and its impact on the live birth outcome of IVF-ET].
    Ma XW; Yin JW; Yang R; Yang S; Li J; Wang Y; Li R
    Zhonghua Fu Chan Ke Za Zhi; 2022 Sep; 57(9):678-685. PubMed ID: 36177579
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients.
    Ren Y; Li R; Yang S; Yang R; Song D
    Arch Gynecol Obstet; 2022 Jun; 305(6):1587-1594. PubMed ID: 35059793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study.
    Hu L; Xie R; Wang M; Sun Y
    Reprod Biol Endocrinol; 2021 Jan; 19(1):8. PubMed ID: 33441149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes.
    Schirmer DA; Kulkarni AD; Zhang Y; Kawwass JF; Boulet SL; Kissin DM
    Fertil Steril; 2020 Sep; 114(3):567-578. PubMed ID: 32680613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between the number of oocytes retrieved for IVF, perinatal outcome and obstetric complications.
    Magnusson Å; Wennerholm UB; Källén K; Petzold M; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Oct; 33(10):1939-1947. PubMed ID: 30124838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal outcomes of singleton live births after late moderate-to-severe ovarian hyperstimulation syndrome: A propensity score-matched study.
    Ran S; Zu R; Wu H; Zheng W; Yang C; Yang S; Ren B; Zhang W; Du J; Guan Y
    Front Endocrinol (Lausanne); 2022; 13():1063066. PubMed ID: 36531504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
    Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of oocytes retrieved during IVF: a balance between efficacy and safety.
    Magnusson Å; Källen K; Thurin-Kjellberg A; Bergh C
    Hum Reprod; 2018 Jan; 33(1):58-64. PubMed ID: 29136154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraphysiologic estradiol is an independent predictor of low birth weight in full-term singletons born after fresh embryo transfer.
    Pereira N; Elias RT; Christos PJ; Petrini AC; Hancock K; Lekovich JP; Rosenwaks Z
    Hum Reprod; 2017 Jul; 32(7):1410-1417. PubMed ID: 28505290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso NN; Hassan R
    Cochrane Database Syst Rev; 2017 May; 5(5):CD002811. PubMed ID: 28535578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association between Ovarian Hyperstimulation Syndrome and Pregnancy Complications following Fertility Treatments.
    Vainer-Rotbart S; Sheiner E; Harlev A; Bar G; Levy A
    Am J Perinatol; 2023 Jul; 40(10):1088-1095. PubMed ID: 34327685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
    Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
    Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstetric outcomes following ovarian hyperstimulation syndrome in IVF - a comparison with uncomplicated fresh and frozen transfer cycles.
    Ganer Herman H; Mizrachi Y; Horowitz E; Weissman A; Sabban B; Gluck O; Raziel A; Kovo M
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):573. PubMed ID: 35850741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
    Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax.
    Ma X; Yin J; Yang R; Yang S; Li J; Wang Y; Li R
    J Clin Med; 2023 Sep; 12(19):. PubMed ID: 37834853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.
    Jiang X; Deng CY; Sun ZY; Chen WL; Wang HB; Zhou YZ; Jin L
    Chin Med J (Engl); 2015 Dec; 128(23):3167-72. PubMed ID: 26612291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fresh versus frozen embryo transfers in assisted reproduction.
    Zaat T; Zagers M; Mol F; Goddijn M; van Wely M; Mastenbroek S
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD011184. PubMed ID: 33539543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
    Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M; Son WY; Buckett W; Tulandi T; Holzer H
    Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.